NAD+ and GHK-CU: The Longevity Peptides Taking the Research World by Storm

The Rise of Longevity Research

Longevity science has moved from the fringe to the forefront of biomedical research. Among the many compounds under investigation, two stand out for their breadth of research and biological significance: NAD+ (Nicotinamide Adenine Dinucleotide) and GHK-CU (Copper Peptide GHK-Cu).

Both are naturally occurring in the human body. Both decline with age. And both are subjects of intense ongoing scientific investigation.

NAD+: The Cellular Energy Coenzyme

NAD+ is a coenzyme found in every living cell. It plays a fundamental role in two critical biological processes:

  • Energy metabolism — NAD+ is essential for the conversion of nutrients into ATP (cellular energy) via glycolysis and the citric acid cycle
  • DNA repair and gene expression — NAD+ is required by sirtuins (SIRT1–7) and PARP enzymes, which regulate DNA repair, inflammation response, and circadian rhythm

The Aging Connection

Research has consistently shown that NAD+ levels decline significantly with age — by as much as 50% between ages 40 and 60 in some tissue types. This decline correlates with reduced mitochondrial function, increased DNA damage accumulation, and metabolic dysregulation — hallmarks of the aging process.

Current Research Directions

  • Mitochondrial function and energy production in aged tissue
  • Sirtuin activation and its relationship to cellular health
  • Neurological protection and cognitive function
  • Metabolic regulation and insulin sensitivity
  • Circadian rhythm and sleep quality in research models

GHK-CU: The Copper Peptide

GHK-Cu (Glycine-Histidine-Lysine complexed with copper) is a naturally occurring tripeptide found in human plasma, saliva, and urine. Like NAD+, its concentration declines with age.

Biological Functions Under Study

GHK-Cu has attracted research interest for its apparent influence on multiple biological pathways:

  • Tissue remodeling — stimulates collagen, elastin, and glycosaminoglycan synthesis
  • Wound healing — promotes angiogenesis and fibroblast proliferation
  • Anti-inflammatory activity — modulates NF-κB signaling and reduces oxidative stress markers in research models
  • Gene expression — studies suggest GHK-Cu influences the expression of over 4,000 human genes, many related to anti-aging pathways
  • Hair follicle research — investigated for its role in hair follicle cycling and dermal papilla activity

The Gene Expression Finding

One of the most striking findings in GHK-Cu research comes from genome analysis work by researcher Loren Pickart, which found that GHK-Cu influences gene expression in ways that appear to partially reverse gene expression patterns associated with aging — restoring them toward patterns seen in younger tissue. This remains an active and exciting area of investigation.

NAD+ vs. GHK-CU: Different Mechanisms, Complementary Research

Compound Primary Research Domain Key Mechanism
NAD+ Cellular energy, DNA repair, metabolism Sirtuin/PARP activation, mitochondrial support
GHK-CU Tissue regeneration, gene expression, skin Collagen synthesis, NF-κB modulation, angiogenesis

Available at My Freedom Peptides

Both NAD+ and GHK-CU are available in our shop, sourced from Star Nutrasciences and independently verified by Freedom Diagnostics Testing at 99%+ purity.

Shop NAD+ and GHK-CU →

All products are for research use only. Not intended for human consumption, treatment, or medical use. These statements have not been evaluated by the FDA.

The Freedom Files

Don’t Miss the Next Article

Join our email list for weekly research insights, new product drops, and exclusive deals.

Join the List

Frequently Asked Questions

How do NAD+ and GHK-Cu differ in their mechanisms of action for longevity research?

NAD+ precursors replenish the NAD+ pool, restoring sirtuin and PARP enzyme activity to support mitochondrial function and DNA repair. GHK-Cu acts at the epigenetic level — modulating gene expression of collagen, anti-inflammatory, and stem cell recruitment factors — making the two compounds mechanistically complementary longevity research tools.

Can NAD+ precursors and GHK-Cu be studied together in the same protocol?

There is no documented pharmacological interaction that would prevent co-study of NAD+ precursors and GHK-Cu. Researchers interested in combinatorial longevity protocols should design appropriate controls for each compound's individual contribution to observed outcomes.

What is the most effective delivery route for GHK-Cu in research settings?

Topical and subcutaneous routes have both been used in published research. Topical GHK-Cu is well-documented for skin collagen studies, while systemic subcutaneous delivery is used in gene expression and whole-organism aging models.

What dosing parameters for NAD+ precursors appear in human clinical trials?

Published NR trials commonly use 300–1,000 mg/day oral doses; NMN trials range from 250–1,250 mg/day. Optimal dosing for specific longevity endpoints remains an active research question, as blood NAD+ elevation does not necessarily confirm proportional tissue-level changes.

Are NAD+ and GHK-Cu peptides available in research-certified formulations?

Yes — both compounds are available as research-grade products from suppliers providing third-party CoA documentation. Researchers should verify HPLC purity ≥98% and mass spectrometry identity for GHK-Cu, and certificate of analysis from accredited labs for NAD+ precursors before initiating studies.

For research use only. Not intended for human consumption.

For research use only. Not intended for human consumption. These statements have not been evaluated by the Food and Drug Administration.